| 摘要 |
The present invention relates to the risk assessment, detection, diagnosis, or prognosis of prostate cancer. More specifically, this invention relates to the detection of certain polymorphism in the promoter region of the MIF gene to determine the risk, detect, diagnose, or prognosticate prostate cancer. Applicants have discovered that the presence of a -173 C and/or -749 (CATT)7 or more repeat predispose an individual to prostate cancer.
|
| 申请人 |
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS;SIEGLER, KATHERINE;ICZKOWSKI, KENNETH;BUCALA, RICHARD;VERA, PEDRO, L. |
发明人 |
SIEGLER, KATHERINE;ICZKOWSKI, KENNETH;BUCALA, RICHARD;VERA, PEDRO, L. |
